A Safety, Tolerability and Pharmacokinetic Study of ABT-102 in Healthy Subjects

Completed · Phase 1 · Has a placebo group

Conditions studied: Healthy Volunteers

In brief

The purpose of this study is to evaluate the safety, tolerability and pharmacokinetics of three different strengths of an investigational product dosed twice a day over 7 days in healthy subjects.

Key facts

Study ID

NCT00854659

Run by

Abbott

People needed

36

Starts

2009-03-01

Last updated by the study team

2010-11-02

Who can join

Age: 18 and older, up to 55. Sex: any. Healthy volunteers: accepted.

You may qualify if…

• Males and Females with a condition of general good health.
• Must be willing to participate in all study-related procedures.

You may not qualify if…

• History of significant sensitivity to any drug.
• Allergy to soy lecithin, soybeans, soybean oil, or other soybean derivatives.
• A requirement for medications, vitamins and/or herbal supplements during the study.
• Pregnant or breast-feeding.
• History of drug or alcohol abuse.
• Positive Hepatitis or HIV test.
• History of certain medical conditions or any uncontrolled medical illness.
• History of certain gastrointestinal surgeries that may interfere with gastrointestinal motility, PH or absorption.
• Current participation in another clinical study or receipt of investigational drug within the past 6 weeks.

Where it is running

• Site Reference ID/Investigator# 18101 — Austin, Texas, United States

Full record on ClinicalTrials.gov

Trial information comes from ClinicalTrials.gov and is refreshed daily. TrialsForMe does not provide medical care and does not run the studies it lists.